Screening of the in vitro antileishmanial activities of compounds and secondary metabolites isolated from Maytenus guianensis Klotzsch ex Reissek (Celastraceae) chichuá Amazon

Abstract INTRODUCTION Maytenus guianensis is a member of the Celastraceae family that is used in traditional medicine, particularly for its anti-parasitic and anti-cancer effects. To explore the ethnopharmacological potential of this plant, the present study was designed to screen the in vitro antileishmanial activities of extracts and compounds isolated from M. guianensis. METHODS Maytenus guianensis stems and leaves were extracted in acetone, followed by the preparation of eluates and isolation of secondary metabolites using chromatography on a glass column with silica gel as the fixed phase. The chemical components were identified using spectroscopic methods, including one- and two-dimensional nuclear magnetic resonance of hydrogen-1 and carbon-13, mass spectroscopy, and infrared spectroscopy. The anti-Leishmania amazonensis activities of these eluates and compounds were evaluated by direct promastigote counting and viability assays. RESULTS It was found that the hexane bark eluate produced the strongest anti-L. amazonensis effect, with 90-100% inhibition of the promastigote form. The isolated metabolite that produced the best result was tingenone B, followed by a compound formed by the union of tingenone and tingenone B (80-90% inhibition). CONCLUSIONS Maytenus guianensis shows anti-parasite activity that warrants further investigation to determine the mechanisms underlying this antileishmanial effect and to evaluate the pharmacological potential of these eluates and isolated secondary metabolites, while minimizing any adverse effects.

Plantas da Amazônia brasileira com potencial leishmanicida in vitro / Plants of the Brazilian Amazon with potential in vitro antileishmania activity

A preocupação em buscar novos fármacos para o tratamento da leishmaniose é cada vez maior em virtude da toxicidade dos existentes e do aumento da resistência do parasito, o que representa uma ameaça ao controle da doença. O presente estudo apresenta uma revisão bibliográfica sobre as plantas da Amazônia brasileira com potencial atividade leishmanicida in vitro. Constatouse uma grande diversidade de espécies vegetais da Amazônia brasileira com potencial para a investigação de novos fitoterápicos e metabólitos secundários com ação leishmanicida, além do tratamento de outras parasitoses negligenciadas. A presente revisão demonstrou que as espécies dos gêneros Casearia, Croton e Physalis são fortes candidatas para busca de novos fármacos, visto que apresentaram um IC50 menor que 1µg/mL em testes in vitro contra as formas promastigotas ou amastigotas de Leishmania spp. Ressalta-se a importância de estudos futuros sobre espécies que apresentem metabólitos terpenoides ou esteroides em virtude do potencial leishmanicida que têm demonstrado.